Searched for
AMLODIPINE BESYLATE
Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.- Wockhardt recalls over 1.62 lakh cartons of drugs in USs per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for...
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
- Dr Reddy's launches generic cholesterol-lowering drug in USDr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.
- Unichem gets USFDA nod for generic hypertension tabletsUnichem Laboratories today said it has received approval from the US health regulator USFDA for its generic amlodipine besylate tablets use...
- Zydus receives anti-hypertensive drug approvalZydus Cadila has received tentative approval from the US drug authorities for two anti-hypertensive drugs.
- Aurobindo Pharma gets USFDA nod for anti-hypertension medicineAurobindo Pharma today said it has received final approvals from the US health regulator to manufacture and market Amlodipine Besylate and ...
- Ranbaxy Laboratories to market Daiichi Sankyo's Sevikarin in RomaniaRanbaxy Labs will market Daiichi Sankyo's antihypertensive drug Sevikarin in Romania expanding its hybrid model strategy to the European co...
- Ranbaxy Laboratories launches generic Cadeut in the American marketDrug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Dr Reddy's launches hypertension capsules Amlodipine Besylate and Benazepril Hydrochloride capsules in US marketDr Reddy's Laboratories on Thursday said it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules in the US market.
- Ranbaxy to launch anti-hypertensive drug in AfricaRanbaxy Laboratories will launch parent company Daiichi Sankyo’s anti-hypertensive drug, Olmesartan Medoxomil, in six African countries und...
- Lupin, Novartis end patent row for LotrelLupin has reached an out-ofcourt settlement with Swiss pharma major Novartis for the latter’s hypertension drug sold under the brand name L...
- Stocks to watch: IOC, BPCL, HPCL, Tata Motors, SAILOil & gas stocks will be in focus after the government hiked fuel prices.
- Glaxo, Pfizer’s patent claims turned downIndian authorities have rejected the patent applications of GlaxoSmithkline’s anti-diabetic drug Avandia and Pfizer’s cholesterol lowering ...
- Ranbaxy, Pfizer settle Lipitor litigation worldwideRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
- Wockhardt gets FDA nod to enter US Norvasc marketWockhardt has launched Amlodipine tablets in US market. The tablets are in strengths of 2.5 mg, 5 mg and 10 mg. The US market for Amlodipin...
- Lupin gets US nod for hypertension drugThe company's Amlodipine Besylate tablets are AB-rated generic equivalent of Pfizer's Norvasc tablets.
- Ranbaxy gets tentative US nod for TamsulosinRanbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories, has received tentative approval from the U.S. Food a...
- Ranbaxy receives USFDA nod for Amlodipine BesylateCountry's biggest pharmaceutical firm Ranbaxy Laboratories on Wednesday said it has received tentative US Food and Drug Administration (USF...
Load More
